Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Alembic Pharma receives EIR from USFDA

      Alembic Pharma receives EIR from USFDA

      Medical Dialogues Bureau18 Jun 2018 10:30 AM IST
      New Delhi: Drug firm Alembic Pharmaceuticals said it has received Establishment Inspection Report from the US health regulator for its formulation...
      Bayer begins Rs 1.3K crore open offer process to buy up to 26 percent stake in Monsanto India

      Bayer begins Rs 1.3K crore open offer process to buy up to 26 percent stake in Monsanto India

      Medical Dialogues Bureau18 Jun 2018 10:00 AM IST
      German chemicals and pharma major Bayer group has launched the process for over Rs 1,300 crore open offer to acquire up to 26 percent additional stake...
      Cipla gets USFDAs final approval for generic Isuprel

      Cipla gets USFDAs final approval for generic Isuprel

      Medical Dialogues Bureau17 Jun 2018 1:34 PM IST
      Mumbai: Cipla, announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection...
      Sanofi Plots Cancer Comeback With First New Drug in Years

      Sanofi Plots Cancer Comeback With First New Drug in Years

      Medical Dialogues Bureau17 Jun 2018 10:41 AM IST
      Bloomberg: Sanofi was a spectator during the last wave of cancer breakthroughs. The French drugmaker is counting on its first new tumor drug in seven...
      StatsMetrika introduces CDISC solutions in India

      StatsMetrika introduces CDISC solutions in India

      Medical Dialogues Bureau17 Jun 2018 9:41 AM IST
      New Delhi: Healthcare solutions provider StatsMetrika launched CDISC (Clinical Data Interchange Standards Consortium) Standards, for the first time in...
      Policybazaar.com to enter healthcare space; to offer online consultation

      Policybazaar.com to enter healthcare space; to offer online consultation

      Medical Dialogues Bureau16 Jun 2018 3:31 PM IST
      ETechAces Marketing and Consulting Pvt. Ltd., which owns India's leading insurtech brand, PolicyBazaar.com and India's leading lending marketplace,...
      Reddys Laboratories gets USFDA nod for generic version of Suboxone

      Reddy's Laboratories gets USFDA nod for generic version of Suboxone

      Medical Dialogues Bureau16 Jun 2018 1:34 PM IST
      New Delhi: Dr Reddy's Laboratories has received final approval from the US health regulator for generic version of Suboxone, prescribed for opioid...
      Setback for Sanofi : Study confirms higher risk of dengue in kids who got Sanofi vaccine

      Setback for Sanofi : Study confirms higher risk of dengue in kids who got Sanofi vaccine

      Medical Dialogues Bureau16 Jun 2018 10:13 AM IST
      CHICAGO (Reuters) - An analysis of data on Sanofi’s dengue vaccine, which has been given to more than 800,000 school children in the Philippines,...
      Lupin launches generic Tobramycin Inhalation Solution USP in the US

      Lupin launches generic Tobramycin Inhalation Solution USP in the US

      Medical Dialogues Bureau16 Jun 2018 10:00 AM IST
      Pharma Major Lupin has announced the launch of its Tobramycin Inhalation Solution USP, having received an approval from the United States Food and...
      Alembic Pharma gets USFDA nod for its Doxycycline Hyclate capsules

      Alembic Pharma gets USFDA nod for its Doxycycline Hyclate capsules

      Medical Dialogues Bureau16 Jun 2018 10:00 AM IST
      Drug firm Alembic Pharmaceuticals today said it has received approval from the US health regulator for its Doxycycline Hyclate capsules used for...
      Strides Shasun shares rise over 5% on USFDA approval for new drug

      Strides Shasun shares rise over 5% on USFDA approval for new drug

      Medical Dialogues Bureau16 Jun 2018 9:12 AM IST
      New Delhi: Shares of Strides Shasun rose by over 5 per cent after the company's subsidiary Strides Pharma Global received final approval from the US...
      Biotech, Pharma Firms Run Away After Industry Party With Topless Dancers

      Biotech, Pharma Firms Run Away After Industry Party With Topless Dancers

      Medical Dialogues Bureau15 Jun 2018 2:53 PM IST
      USA: Biotechnology and pharma companies scrambled to distance themselves from an industry party where topless dancers’ bodies were painted with...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok